Global Renin-Angiotensin-System (RAS)-Acting Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Renin-Angiotensin-System (RAS)-Acting Agent market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Renin-Angiotensin-System (RAS)-Acting Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Renin-Angiotensin-System (RAS)-Acting Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Renin-Angiotensin-System (RAS)-Acting Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Renin-Angiotensin-System (RAS)-Acting Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Renin-Angiotensin-System (RAS)-Acting Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Renin-Angiotensin-System (RAS)-Acting Agent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Renin-Angiotensin-System (RAS)-Acting Agent market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc. and Sanofi S.A., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Renin-Angiotensin-System (RAS)-Acting Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Renin-Angiotensin-System (RAS)-Acting Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Renin-Angiotensin-System (RAS)-Acting Agent, with price, sales, revenue and global market share of Renin-Angiotensin-System (RAS)-Acting Agent from 2018 to 2023.
Chapter 3, the Renin-Angiotensin-System (RAS)-Acting Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Renin-Angiotensin-System (RAS)-Acting Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Renin-Angiotensin-System (RAS)-Acting Agent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Renin-Angiotensin-System (RAS)-Acting Agent.
Chapter 14 and 15, to describe Renin-Angiotensin-System (RAS)-Acting Agent sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Renin-Angiotensin-System (RAS)-Acting Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Renin-Angiotensin-System (RAS)-Acting Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Renin-Angiotensin-System (RAS)-Acting Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Renin-Angiotensin-System (RAS)-Acting Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Renin-Angiotensin-System (RAS)-Acting Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Renin-Angiotensin-System (RAS)-Acting Agent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Renin-Angiotensin-System (RAS)-Acting Agent market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc. and Sanofi S.A., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Renin-Angiotensin-System (RAS)-Acting Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Angiotensin Converting Enzyme Inhibitors (ACEi)
- Angiotensin Receptor Blockers (ARBs)
- Hypertension
- Heart Failure
- Chronic Kidney Disease
- Other
- Novartis AG
- Pfizer, Inc.
- AstraZeneca plc
- Merck & Co., Inc.
- Sanofi S.A.
- Bristol-Myers Squibb Company
- Daiichi Sankyo Company,Limited
- Takeda Pharmaceutical Company Limited
- Boehringer lngelheim GmbH
- Johnson & Johnson
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Renin-Angiotensin-System (RAS)-Acting Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Renin-Angiotensin-System (RAS)-Acting Agent, with price, sales, revenue and global market share of Renin-Angiotensin-System (RAS)-Acting Agent from 2018 to 2023.
Chapter 3, the Renin-Angiotensin-System (RAS)-Acting Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Renin-Angiotensin-System (RAS)-Acting Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Renin-Angiotensin-System (RAS)-Acting Agent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Renin-Angiotensin-System (RAS)-Acting Agent.
Chapter 14 and 15, to describe Renin-Angiotensin-System (RAS)-Acting Agent sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Renin-Angiotensin-System (RAS)-Acting Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Angiotensin Converting Enzyme Inhibitors (ACEi)
1.3.3 Angiotensin Receptor Blockers (ARBs)
1.4 Market Analysis by Application
1.4.1 Overview: Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hypertension
1.4.3 Heart Failure
1.4.4 Chronic Kidney Disease
1.4.5 Other
1.5 Global Renin-Angiotensin-System (RAS)-Acting Agent Market Size & Forecast
1.5.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (2018-2029)
1.5.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.1.4 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Pfizer, Inc.
2.2.1 Pfizer, Inc. Details
2.2.2 Pfizer, Inc. Major Business
2.2.3 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.2.4 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer, Inc. Recent Developments/Updates
2.3 AstraZeneca plc
2.3.1 AstraZeneca plc Details
2.3.2 AstraZeneca plc Major Business
2.3.3 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.3.4 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca plc Recent Developments/Updates
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business
2.4.3 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.4.4 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co., Inc. Recent Developments/Updates
2.5 Sanofi S.A.
2.5.1 Sanofi S.A. Details
2.5.2 Sanofi S.A. Major Business
2.5.3 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.5.4 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi S.A. Recent Developments/Updates
2.6 Bristol-Myers Squibb Company
2.6.1 Bristol-Myers Squibb Company Details
2.6.2 Bristol-Myers Squibb Company Major Business
2.6.3 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.6.4 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.7 Daiichi Sankyo Company,Limited
2.7.1 Daiichi Sankyo Company,Limited Details
2.7.2 Daiichi Sankyo Company,Limited Major Business
2.7.3 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.7.4 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Daiichi Sankyo Company,Limited Recent Developments/Updates
2.8 Takeda Pharmaceutical Company Limited
2.8.1 Takeda Pharmaceutical Company Limited Details
2.8.2 Takeda Pharmaceutical Company Limited Major Business
2.8.3 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.8.4 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.9 Boehringer lngelheim GmbH
2.9.1 Boehringer lngelheim GmbH Details
2.9.2 Boehringer lngelheim GmbH Major Business
2.9.3 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.9.4 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boehringer lngelheim GmbH Recent Developments/Updates
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.10.4 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Johnson & Johnson Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RENIN-ANGIOTENSIN-SYSTEM (RAS)-ACTING AGENT BY MANUFACTURER
3.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue by Manufacturer (2018-2023)
3.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Renin-Angiotensin-System (RAS)-Acting Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Renin-Angiotensin-System (RAS)-Acting Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Renin-Angiotensin-System (RAS)-Acting Agent Manufacturer Market Share in 2022
3.5 Renin-Angiotensin-System (RAS)-Acting Agent Market: Overall Company Footprint Analysis
3.5.1 Renin-Angiotensin-System (RAS)-Acting Agent Market: Region Footprint
3.5.2 Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Type Footprint
3.5.3 Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Region
4.1.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2029)
4.1.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2018-2029)
4.2 North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
4.3 Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
4.5 South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
5.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type (2018-2029)
5.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
6.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application (2018-2029)
6.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
7.2 North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
7.3 North America Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Country
7.3.1 North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
8.2 Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
8.3 Europe Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Country
8.3.1 Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Region
9.3.1 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
10.2 South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
10.3 South America Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Country
10.3.1 South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Country
11.3.1 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Renin-Angiotensin-System (RAS)-Acting Agent Market Drivers
12.2 Renin-Angiotensin-System (RAS)-Acting Agent Market Restraints
12.3 Renin-Angiotensin-System (RAS)-Acting Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Renin-Angiotensin-System (RAS)-Acting Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Renin-Angiotensin-System (RAS)-Acting Agent
13.3 Renin-Angiotensin-System (RAS)-Acting Agent Production Process
13.4 Renin-Angiotensin-System (RAS)-Acting Agent Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Renin-Angiotensin-System (RAS)-Acting Agent Typical Distributors
14.3 Renin-Angiotensin-System (RAS)-Acting Agent Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Renin-Angiotensin-System (RAS)-Acting Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Angiotensin Converting Enzyme Inhibitors (ACEi)
1.3.3 Angiotensin Receptor Blockers (ARBs)
1.4 Market Analysis by Application
1.4.1 Overview: Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hypertension
1.4.3 Heart Failure
1.4.4 Chronic Kidney Disease
1.4.5 Other
1.5 Global Renin-Angiotensin-System (RAS)-Acting Agent Market Size & Forecast
1.5.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (2018-2029)
1.5.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.1.4 Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Pfizer, Inc.
2.2.1 Pfizer, Inc. Details
2.2.2 Pfizer, Inc. Major Business
2.2.3 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.2.4 Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer, Inc. Recent Developments/Updates
2.3 AstraZeneca plc
2.3.1 AstraZeneca plc Details
2.3.2 AstraZeneca plc Major Business
2.3.3 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.3.4 AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca plc Recent Developments/Updates
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business
2.4.3 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.4.4 Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co., Inc. Recent Developments/Updates
2.5 Sanofi S.A.
2.5.1 Sanofi S.A. Details
2.5.2 Sanofi S.A. Major Business
2.5.3 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.5.4 Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi S.A. Recent Developments/Updates
2.6 Bristol-Myers Squibb Company
2.6.1 Bristol-Myers Squibb Company Details
2.6.2 Bristol-Myers Squibb Company Major Business
2.6.3 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.6.4 Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.7 Daiichi Sankyo Company,Limited
2.7.1 Daiichi Sankyo Company,Limited Details
2.7.2 Daiichi Sankyo Company,Limited Major Business
2.7.3 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.7.4 Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Daiichi Sankyo Company,Limited Recent Developments/Updates
2.8 Takeda Pharmaceutical Company Limited
2.8.1 Takeda Pharmaceutical Company Limited Details
2.8.2 Takeda Pharmaceutical Company Limited Major Business
2.8.3 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.8.4 Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.9 Boehringer lngelheim GmbH
2.9.1 Boehringer lngelheim GmbH Details
2.9.2 Boehringer lngelheim GmbH Major Business
2.9.3 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.9.4 Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boehringer lngelheim GmbH Recent Developments/Updates
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
2.10.4 Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Johnson & Johnson Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RENIN-ANGIOTENSIN-SYSTEM (RAS)-ACTING AGENT BY MANUFACTURER
3.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue by Manufacturer (2018-2023)
3.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Renin-Angiotensin-System (RAS)-Acting Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Renin-Angiotensin-System (RAS)-Acting Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Renin-Angiotensin-System (RAS)-Acting Agent Manufacturer Market Share in 2022
3.5 Renin-Angiotensin-System (RAS)-Acting Agent Market: Overall Company Footprint Analysis
3.5.1 Renin-Angiotensin-System (RAS)-Acting Agent Market: Region Footprint
3.5.2 Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Type Footprint
3.5.3 Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Region
4.1.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2029)
4.1.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2018-2029)
4.2 North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
4.3 Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
4.5 South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
5.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type (2018-2029)
5.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
6.2 Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application (2018-2029)
6.3 Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
7.2 North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
7.3 North America Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Country
7.3.1 North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
8.2 Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
8.3 Europe Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Country
8.3.1 Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Region
9.3.1 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
10.2 South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
10.3 South America Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Country
10.3.1 South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Market Size by Country
11.3.1 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Renin-Angiotensin-System (RAS)-Acting Agent Market Drivers
12.2 Renin-Angiotensin-System (RAS)-Acting Agent Market Restraints
12.3 Renin-Angiotensin-System (RAS)-Acting Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Renin-Angiotensin-System (RAS)-Acting Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Renin-Angiotensin-System (RAS)-Acting Agent
13.3 Renin-Angiotensin-System (RAS)-Acting Agent Production Process
13.4 Renin-Angiotensin-System (RAS)-Acting Agent Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Renin-Angiotensin-System (RAS)-Acting Agent Typical Distributors
14.3 Renin-Angiotensin-System (RAS)-Acting Agent Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 6. Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer, Inc. Major Business
Table 10. Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 11. Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer, Inc. Recent Developments/Updates
Table 13. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca plc Major Business
Table 15. AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 16. AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AstraZeneca plc Recent Developments/Updates
Table 18. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co., Inc. Major Business
Table 20. Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 21. Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck & Co., Inc. Recent Developments/Updates
Table 23. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi S.A. Major Business
Table 25. Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 26. Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi S.A. Recent Developments/Updates
Table 28. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 29. Bristol-Myers Squibb Company Major Business
Table 30. Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 31. Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bristol-Myers Squibb Company Recent Developments/Updates
Table 33. Daiichi Sankyo Company,Limited Basic Information, Manufacturing Base and Competitors
Table 34. Daiichi Sankyo Company,Limited Major Business
Table 35. Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 36. Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Daiichi Sankyo Company,Limited Recent Developments/Updates
Table 38. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Pharmaceutical Company Limited Major Business
Table 40. Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 41. Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 43. Boehringer lngelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer lngelheim GmbH Major Business
Table 45. Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 46. Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boehringer lngelheim GmbH Recent Developments/Updates
Table 48. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Major Business
Table 50. Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 51. Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Renin-Angiotensin-System (RAS)-Acting Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Renin-Angiotensin-System (RAS)-Acting Agent Production Site of Key Manufacturer
Table 58. Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Type Footprint
Table 59. Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Application Footprint
Table 60. Renin-Angiotensin-System (RAS)-Acting Agent New Market Entrants and Barriers to Market Entry
Table 61. Renin-Angiotensin-System (RAS)-Acting Agent Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Renin-Angiotensin-System (RAS)-Acting Agent Raw Material
Table 121. Key Manufacturers of Renin-Angiotensin-System (RAS)-Acting Agent Raw Materials
Table 122. Renin-Angiotensin-System (RAS)-Acting Agent Typical Distributors
Table 123. Renin-Angiotensin-System (RAS)-Acting Agent Typical Customers
Table 1. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 6. Novartis AG Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer, Inc. Major Business
Table 10. Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 11. Pfizer, Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer, Inc. Recent Developments/Updates
Table 13. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca plc Major Business
Table 15. AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 16. AstraZeneca plc Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AstraZeneca plc Recent Developments/Updates
Table 18. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co., Inc. Major Business
Table 20. Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 21. Merck & Co., Inc. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck & Co., Inc. Recent Developments/Updates
Table 23. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi S.A. Major Business
Table 25. Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 26. Sanofi S.A. Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi S.A. Recent Developments/Updates
Table 28. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 29. Bristol-Myers Squibb Company Major Business
Table 30. Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 31. Bristol-Myers Squibb Company Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bristol-Myers Squibb Company Recent Developments/Updates
Table 33. Daiichi Sankyo Company,Limited Basic Information, Manufacturing Base and Competitors
Table 34. Daiichi Sankyo Company,Limited Major Business
Table 35. Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 36. Daiichi Sankyo Company,Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Daiichi Sankyo Company,Limited Recent Developments/Updates
Table 38. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Pharmaceutical Company Limited Major Business
Table 40. Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 41. Takeda Pharmaceutical Company Limited Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 43. Boehringer lngelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer lngelheim GmbH Major Business
Table 45. Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 46. Boehringer lngelheim GmbH Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boehringer lngelheim GmbH Recent Developments/Updates
Table 48. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Major Business
Table 50. Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Product and Services
Table 51. Johnson & Johnson Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Renin-Angiotensin-System (RAS)-Acting Agent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Renin-Angiotensin-System (RAS)-Acting Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Renin-Angiotensin-System (RAS)-Acting Agent Production Site of Key Manufacturer
Table 58. Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Type Footprint
Table 59. Renin-Angiotensin-System (RAS)-Acting Agent Market: Company Product Application Footprint
Table 60. Renin-Angiotensin-System (RAS)-Acting Agent New Market Entrants and Barriers to Market Entry
Table 61. Renin-Angiotensin-System (RAS)-Acting Agent Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Renin-Angiotensin-System (RAS)-Acting Agent Raw Material
Table 121. Key Manufacturers of Renin-Angiotensin-System (RAS)-Acting Agent Raw Materials
Table 122. Renin-Angiotensin-System (RAS)-Acting Agent Typical Distributors
Table 123. Renin-Angiotensin-System (RAS)-Acting Agent Typical Customers
LIST OF FIGURES
Figure 1. Renin-Angiotensin-System (RAS)-Acting Agent Picture
Figure 2. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Type in 2022
Figure 4. Angiotensin Converting Enzyme Inhibitors (ACEi) Examples
Figure 5. Angiotensin Receptor Blockers (ARBs) Examples
Figure 6. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Application in 2022
Figure 8. Hypertension Examples
Figure 9. Heart Failure Examples
Figure 10. Chronic Kidney Disease Examples
Figure 11. Other Examples
Figure 12. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Renin-Angiotensin-System (RAS)-Acting Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Renin-Angiotensin-System (RAS)-Acting Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Renin-Angiotensin-System (RAS)-Acting Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Region (2018-2029)
Figure 54. China Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Renin-Angiotensin-System (RAS)-Acting Agent Market Drivers
Figure 75. Renin-Angiotensin-System (RAS)-Acting Agent Market Restraints
Figure 76. Renin-Angiotensin-System (RAS)-Acting Agent Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Renin-Angiotensin-System (RAS)-Acting Agent in 2022
Figure 79. Manufacturing Process Analysis of Renin-Angiotensin-System (RAS)-Acting Agent
Figure 80. Renin-Angiotensin-System (RAS)-Acting Agent Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Renin-Angiotensin-System (RAS)-Acting Agent Picture
Figure 2. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Type in 2022
Figure 4. Angiotensin Converting Enzyme Inhibitors (ACEi) Examples
Figure 5. Angiotensin Receptor Blockers (ARBs) Examples
Figure 6. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Application in 2022
Figure 8. Hypertension Examples
Figure 9. Heart Failure Examples
Figure 10. Chronic Kidney Disease Examples
Figure 11. Other Examples
Figure 12. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Renin-Angiotensin-System (RAS)-Acting Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Renin-Angiotensin-System (RAS)-Acting Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Renin-Angiotensin-System (RAS)-Acting Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Renin-Angiotensin-System (RAS)-Acting Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Region (2018-2029)
Figure 54. China Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Renin-Angiotensin-System (RAS)-Acting Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Renin-Angiotensin-System (RAS)-Acting Agent Market Drivers
Figure 75. Renin-Angiotensin-System (RAS)-Acting Agent Market Restraints
Figure 76. Renin-Angiotensin-System (RAS)-Acting Agent Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Renin-Angiotensin-System (RAS)-Acting Agent in 2022
Figure 79. Manufacturing Process Analysis of Renin-Angiotensin-System (RAS)-Acting Agent
Figure 80. Renin-Angiotensin-System (RAS)-Acting Agent Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
